Bristol-Myers Squibb’s Recent >$20bn M&A Spree Should Reward Patient Investors (NYSE:BMY)

[ad_1]

Keyboard with a green button - Order now

Zerbor/iStock via Getty Images

Investment Overview

Bristol-Myers Squibb Company (NYSE:BMY), the Princeton, New Jersey-based Big Pharma concern, experienced a poor year in terms of share price performance in 2023.

BMY is currently the seventh largest of the “Big 8” U.S.-headquartered global

[ad_2]
Source link

Leave a Reply

Your email address will not be published. Required fields are marked *